A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06198426 · TERMINATED
Trial details
- NCT number
- NCT06198426
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-12-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.